RelieVRx (Pico G3)— 510(k) K251519

Substantially Equivalent

Appliedvr

FDA 510(k) clearance K251519 for RelieVRx (Pico G3), Substantially Equivalent on 2025-08-13. Applicant: Appliedvr.

Clearance details

Applicant: Appliedvr
Product code: Code QRA
Advisory panel: Neurology
Date received: 2025-05-16
Decision date: 2025-08-13
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Van Nuys, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.